HIV-NAT is affiliated with The Thai Red Cross AIDS Research Centre in Bangkok, Thailand, with the Kirby Institute for infection and immunity in society in Sydney, Australia, and with the Amsterdam Institute for Global Health and Development in Amsterdam, The Netherlands. Since 1996 our centre has been conducting clinical research in HIV, meeting international standards, and gaining vast experience in the coordination of multicentre trials in Thailand.
One of the best HIV medicine conferences in Asia Pacific, the Bangkok International Symposium brings together experts in the HIV field from all over the world. The next Symposium will take place from 13-15 January 2016.
The Symposium Series training workshops are centered on care management and treatment for people living with HIV/AIDS. The purpose of the training workshop is to provide in-depth knowledge on HIV care and treatment to medical doctors, nurses, pharmacists and healthcare practitioners. The training workshops are conducted in Thai.
In 2014 HIV-NAT organized various trainings to provide knowledge and information on clinical research and HIV infection management to health care professionals in Thailand and around the world. These trainings include:
4th HIV-NAT Symposium Series
Long-term care and disease prevention in HIV patients at the Tawana Bangkok Hotel on 3-4 July 2014
HIV-NAT/Gilead Medical Education Program in Asia
- Course 1: Regional Best Practices Sharing in HIV
22-26 September 2014
- Course 2: HIV prevention and care from Theory
Practice on 15-17 October 2014
21 May 2015
Basic Life Support (CPR)
11 June 2015
GCP & HSP
2-3 July 2015
5th HIV-NAT Mini Symposium
6 August 2015
In-service lecture 2/2558 (Acute HIV infection & HIV cure research) by Dr. Jintanat
13-15 Jan 2016
The 18th Bangkok International Symposium on HIV Medicine
- Gary Maartens, Graeme Meintjes. Lower-dose efavirenz: what is needed before implementation?. Lancet Infect Dis 2015.
- ENCORE1 Study Group. Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study. Lancet Infect Dis 2015.
- Stephen J. Kerr, Baralee Punyawudho, Narukjaporn Thammajaruk, Angela Colbers, Prachya Chaiyahong, Supalak Phonphithak, Vorapot Sapsirisavat, Kiat Ruxrungtham, David M. Burger, and Anchalee Avihingsanon. Factors Associated with Daily Tenofovir Exposure in Thai Subjects Taking Combination Antiretroviral Therapy. Aids Research And Human Retroviruses 2015;31:368-374.DOI: 10.1089/aid.2014.0249
The liver is the body’s largest gland: an adult human liver weighs between 3.2 and 3.7 pounds. It sits to the right of the stomach where it not only detoxifies the blood, but also aids in digestion by creating bile, which helps break down fats... read more at healthline.com